Cargando…

Network and pathway-based analysis of genes associated with esophageal squamous cell carcinoma

BACKGROUND: Although diagnostic methods and treatments have improved over the last few years, the 5-year survival rate of esophageal squamous cell carcinoma (ESCC) patients remains generally poor. The development of high-throughput technology has facilitated great achievements in localization of ESC...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wenwu, Yuan, Kun, He, Jinlan, Wang, Chenghao, Peng, Lin, Han, Yongtao, Chen, Nianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929830/ https://www.ncbi.nlm.nih.gov/pubmed/36819552 http://dx.doi.org/10.21037/atm-22-6512

Ejemplares similares

A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma
por: He, Wenwu, et al.
Publicado: (2019)

Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History
por: He, Wenwu, et al.
Publicado: (2020)

The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: He, Wenwu, et al.
Publicado: (2023)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023)

Identification of tumor-infiltrating lymphocyte subpopulations correlated with patient prognosis in esophageal squamous cell carcinoma
por: Peng, Lin, et al.
Publicado: (2021)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022)

Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
por: He, Wenwu, et al.
Publicado: (2021)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis
por: Li, Kexun, et al.
Publicado: (2023)

The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Deng, Xuyang, et al.
Publicado: (2021)

CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2− Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis
por: Zeng, Ni, et al.
Publicado: (2023)

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma
por: Han, Jiaqi, et al.
Publicado: (2023)

m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma
por: Liu, Zijian, et al.
Publicado: (2022)

The current state of artificial intelligence in endoscopic diagnosis of early esophageal squamous cell carcinoma
por: Pan, Yuwei, et al.
Publicado: (2023)

Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
por: Cao, Bangrong, et al.
Publicado: (2022)

Identification of m6A modification patterns and development of m6A–hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer
por: Shen, Xi, et al.
Publicado: (2022)

Identification of methylated-differentially expressed genes and pathways in esophageal squamous cell carcinoma
por: Sang, Liang, et al.
Publicado: (2020)

Identification of key genes and pathways associated with esophageal squamous cell carcinoma development based on weighted gene correlation network analysis
por: Shao, Mingrui, et al.
Publicado: (2020)

Nomogram-Based Survival Predictions and Treatment Recommendations for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Upfront Surgery
por: Zhu, Jie, et al.
Publicado: (2022)

Gene set enrichment analysis and meta-analysis identified 12 key genes regulating and controlling the prognosis of lung adenocarcinoma
por: He, Wenwu, et al.
Publicado: (2019)

Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma
por: Rao, Wen-Qing, et al.
Publicado: (2023)

Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis
por: Chen, Xiaohua, et al.
Publicado: (2018)

Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
por: Shen, Zhimin, et al.
Publicado: (2021)

Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China
por: Liang, He, et al.
Publicado: (2017)

Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
por: Huang, Han-Ming, et al.
Publicado: (2022)

Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
por: He, Jinxian, et al.
Publicado: (2023)

Precision screening for esophageal squamous cell carcinoma in China
por: He, Zhonghu, et al.
Publicado: (2020)

The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma
por: Xiaoyu, He, et al.
Publicado: (2018)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma
por: Yang, Yu-Shang, et al.
Publicado: (2017)

Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy
por: Zhou, Yehan, et al.
Publicado: (2023)

Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic Chemotherapy
por: Liao, Wenjun, et al.
Publicado: (2020)

Gene mutations of esophageal squamous cell carcinoma based on next-generation sequencing
por: Wang, Long, et al.
Publicado: (2021)

Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma
por: Wu, Bingli, et al.
Publicado: (2014)

Exploration of gene functions for esophageal squamous cell carcinoma using network-based guilt by association principle
por: Wu, Wei, et al.
Publicado: (2018)

Identification and Characterization of Copy Number-Associated Driver Genes in Esophageal Squamous Cell Carcinoma
por: Jiang, Kexin, et al.
Publicado: (2020)

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
por: Luo, Qiyu, et al.
Publicado: (2021)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma
por: Chen, Fang-Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qseqqk8gishg8vlctadg3mnq6m